Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01985126 |
|---|---|
| Brief Title: | An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD |
| First Submitted : | July 22, 2013 |
| First Submitted that Met QC Criteria : | November 7, 2013 |
| First Posted : | November 15, 2013 (Estimate) |
| Results First Submitted : | September 30, 2016 |
| Results First Submitted that Met QC Criteria : | December 9, 2016 |
| Results First Posted : | February 2, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 21, 2018 |
| Last Update Posted : | June 25, 2018 |